Flow cytometry analysis of purified cells showed an enrichment for CD31, ranging from 89.9 to 95.8% of CD31+ cells (Fig. 1C), highlighting the endothelial purity of the CD31-purified fraction from HUVEC/NSCLC cocultures. This evidence concerns the gene PECAM1 and non-small cell lung carcinoma.